CD6 is a cell surface protein expressed primarily by T-lymphocytes The increase in CD6 expression that occurs during thymocyte maturation, and following T-lymphocyte activation, indicates an important role for CD6 in these processes. Exploring the function of CD6 is the focus of this proposal. The T cell co-stimulatory molecule CD2 is important in thymocyte selection, and increase in CD6 are induced by stimulation of thymocyte CD2; this raises the possibility that the CD2 induced survival-signal may be mediated by CD6. Although CD6 has not yet been shown to be important during thymic selection, the CD6 ligand, CD166 is expressed on thymic epithelium, and stimulation of CD6 in chronic lymphocytic leukemia B-cells does decrease apoptotic death. Experiments are proposed to study developmental regulation of CD6 expression and phosphorylation by CD2, and to determine if CD2-induced increased in CD6 expression enhance thymocyte survival. CD6 is also increased in activated T lymphocytes, and in autoreactive cloned T lymphocytes. Data showing that anti-CD6 monoclonal antibody UMCD6 inhibits autoreactive responses of such clones in vitro suggests that CD6 may act as a co-stimulatory molecule in vivo during autoimmunity. Survival of autoreactive T lymphocytes has been reported to contribute to autoimmunity in human SLE but a role for CD6 in hum SLE, has not yet been shown. Studies to determine if alterations in the regulation of CD6 and CD6 phosphorylation occur in SLE T cells, and to assess the role of CD6 in co-activation of SLE T cells are proposed in this application. We hypothesize that the function of the T lymphocyte co-stimulatory molecule CD6 is to enhance T-cell survival during thymocyte development, and to transduce activating signals to mature T lymphocyte. Testing the role of CD6 during thymic selection, and n activation in mature T lymphocyte from SLE patients and normal controls, is expected to enhance our understanding of the role of CD6 in human autoimmune disease.

Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2009) Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5. Biochim Biophys Acta 1790:161-72
Atif, U; Philip, A; Aponte, J et al. (2008) Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 16:1174-7
Kraus, V B; Jordan, J M; Doherty, M et al. (2007) The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 15:120-7
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2006) Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 1760:472-86
Holderbaum, D; Malvitz, T; Ciesielski, C J et al. (2005) A newly described hereditary cartilage debonding syndrome. Arthritis Rheum 52:3300-4
Denko, Charles W; Malemud, Charles J (2005) Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 35:24-34
Ievers-Landis, Carolyn E; Burant, Christopher; Drotar, Dennis et al. (2005) A randomized controlled trial for the primary prevention of osteoporosis among preadolescent girl scouts: 1-year outcomes of a behavioral program. J Pediatr Psychol 30:155-65
Vashishth, D (2005) Collagen glycation and its role in fracture properties of bone. J Musculoskelet Neuronal Interact 5:316
Denko, Charles W; Malemud, Charles J (2005) Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 25:146-51
Denko, Charles W; Malemud, Charles J (2004) Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus. BMC Musculoskelet Disord 5:37

Showing the most recent 10 out of 92 publications